Is one study enough to claim the benefits of Protandim?
Yes. When clinical studies are conducted, researchers are required to conduct a “power analysis” to determine the minimum number of patients required to show the effectiveness of a drug treatment or intervention. For Protandim, a power analysis was conducted to determine the sample size for a human study. The result of the power analysis for Protandim showed that a human study including at least 13 patients would give statistically significant results. While the Protandim clinical study with 29 patients is sufficient to demonstrate the effectiveness from a scientific perspective, additional studies are underway to validate the initial results as well as provide additional benefits relating to specific health conditions.
